384.54999 EUR
0.6
0.16%
Last update Dec 15, 5:30 PM CET
Main market
Day range
383.95001
389.35001
Previous close
385.14999
Open
388.39999
Access this stock data via API
Subscribe
Vertex Pharmaceuticals Inc.
384.55
0.60
0.16%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 9.4B 9.9B 8.9B 7.6B
Cost of revenue 1.3B 1.3B 1.1B 904.2M
Gross profit 8.1B 8.6B 7.9B 6.7B
Operating expense
Research & development 7.0B 3.2B 2.5B 1.9B
Selling general and admin 1.2B 1.1B 944.7M 840.1M
Other operating expenses
Operating income -198.9M 4.3B 4.4B 3.9B
Non operating interest income
Income 509.7M 614.7M 144.6M 4.9M
Expense 26.1M 44.1M 54.8M 61.5M
Other income expense -73.0M -498.3M -222.8M -1.1B
Pretax income 211.8M 4.4B 4.2B 2.7B
Tax provision 668.2M 760.2M 910.4M 388.3M
Net income -456.5M 3.6B 3.3B 2.3B
Basic EPS -2.1 14.1 13.0 9.1
Diluted EPS -2.1 13.9 12.8 9.0
Basic average shares 219.8M 268.8M 263.0M 264.6M
Diluted average shares 219.8M 268.8M 263.0M 264.6M
EBITDA 414.0M 5.1B 4.5B 4.0B
Net income from continuing op. -456.5M 3.6B 3.3B 2.3B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 4 hours 49 minutes

12:55
00:00
09:00
17:45
23:59

Trading Hours (Monday - Friday):

Pre-market
07:00 - 09:00
Main market
09:00 - 17:45
Post-market
17:30 - 20:30
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).